1672P Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic chemotherapy (MEC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1644 ◽

2021 ◽

Vol 32 ◽

pp. S1175

Author(s):

L. Zelek ◽

P. Debourdeau ◽

H. Bourgeois ◽

J.P. Wagner ◽

F. Brocard ◽

...

Keyword(s):

Risk Factors ◽

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy

Download Full-text

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancers receiving moderately emetogenic chemotherapy regimens

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.04.370 ◽

2018 ◽

Vol 149 ◽

pp. 161-162

Author(s):

C. Weinstein ◽

K. Jordan ◽

S. Green ◽

S. Khanani ◽

E. Beckford-Brathwaite ◽

...

Keyword(s):

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy ◽

Gynecologic Cancers

Download Full-text

Abstract P6-11-11: Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer receiving moderately emetogenic chemotherapy regimens

10.1158/1538-7445.sabcs17-p6-11-11 ◽

2018 ◽

Author(s):

C Weinstein ◽

K Jordan ◽

S Green ◽

S Khanani ◽

E Beckford-Brathwaite ◽

...

Keyword(s):

Breast Cancer ◽

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy

Download Full-text

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gastrointestinal cancers receiving moderately emetogenic chemotherapy regimens

Annals of Oncology ◽

10.1093/annonc/mdx261.290 ◽

2017 ◽

Vol 28 ◽

pp. iii102

Author(s):

Cindy Weinstein ◽

Karin Jordan ◽

Stuart Green ◽

Saleem Khanani ◽

Elizabeth Beckford-Brathwaite ◽

...

Keyword(s):

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy ◽

Gastrointestinal Cancers

Download Full-text

Phase III design for a trial of single-dose fosaprepitant (FA) in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps9664 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS9664-TPS9664

Author(s):

Stephen Joseph Noga ◽

Cindy Weinstein ◽

Elber S Camacho ◽

Saleem A Khanani ◽

Elizabeth Beckford-Brathwaite ◽

...

Keyword(s):

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Phase Iii ◽

Moderately Emetogenic Chemotherapy

Download Full-text

A phase III, randomized, double-blind study of single-dose intravenous fosaprepitant in preventing chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.9629 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 9629-9629 ◽

Cited By ~ 1

Author(s):

Bernardo Leon Rapoport ◽

Cindy Weinstein ◽

Elber S. Camacho ◽

Saleem A. Khanani ◽

Elizabeth Beckford-Brathwaite ◽

...

Keyword(s):

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Moderately Emetogenic Chemotherapy ◽

Double Blind

Download Full-text

Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial

The Journal of Supportive Oncology ◽

10.1016/j.suponc.2011.06.007 ◽

2012 ◽

Vol 10 (2) ◽

pp. 65-71 ◽

Cited By ~ 15

Author(s):

Luigi Celio ◽

Angela Denaro ◽

Francesco Agustoni ◽

Emilio Bajetta

Keyword(s):

Risk Factors ◽

Treatment Outcome ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Phase Iii ◽

Moderately Emetogenic Chemotherapy ◽

Phase Iii Trial

Download Full-text

Risk factors for nausea and vomiting (NV) following highly or moderately emetogenic chemotherapy (HEC or MEC) in U.S. community oncology practice.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e19531 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e19531-e19531

Author(s):

J. W. Gilmore ◽

B. A. Feinberg ◽

T. Wisniewski ◽

S. Haislip ◽

C. Wentworth ◽

...

Keyword(s):

Risk Factors ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy ◽

Community Oncology ◽

Oncology Practice

Download Full-text

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial

Annals of Oncology ◽

10.1093/annonc/mdv482 ◽

2016 ◽

Vol 27 (1) ◽

pp. 172-178 ◽

Cited By ~ 28

Author(s):

C. Weinstein ◽

K. Jordan ◽

S.A. Green ◽

E. Camacho ◽

S. Khanani ◽

...

Keyword(s):

Single Dose ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Phase Iii ◽

Moderately Emetogenic Chemotherapy ◽

Double Blind ◽

Phase Iii Trial

Download Full-text

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Supportive Care in Cancer ◽

10.1007/s00520-010-0974-y ◽

2010 ◽

Vol 19 (10) ◽

pp. 1505-1510 ◽

Cited By ~ 13

Author(s):

Nicola Di Renzo ◽

Antonella Montanini ◽

Donato Mannina ◽

Alessandra Dondi ◽

Stefania Muci ◽

...

Keyword(s):

Single Dose ◽

Phase Ii ◽

Hodgkin’S Lymphoma ◽

Phase Ii Study ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Hodgkin's Lymphoma ◽

Moderately Emetogenic Chemotherapy ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Download Full-text

Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patients

Tumori Journal ◽

10.1177/030089161109700318 ◽

2011 ◽

Vol 97 (3) ◽

pp. 362-366 ◽

Cited By ~ 9

Author(s):

Silvia Brugnatelli ◽

Elisabetta Gattoni ◽

Donatella Grasso ◽

Franca Rossetti ◽

Tania Perrone ◽

...

Keyword(s):

Colorectal Cancer ◽

Single Dose ◽

Cancer Patients ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Moderately Emetogenic Chemotherapy ◽

Colorectal Cancer Patients

Download Full-text